Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST 106-2321-B-400-009, MOST 107-2321-B-400-006, MOST 108-2321-B-400-012)
National Health Research Institutes, Taiwan (MR-108-GP-08)
Received: 14 November 2019
Accepted: 27 March 2020
First Online: 14 April 2020
Ethics approval and consent to participate
: Animal studies were approved by the Animal Committee of the National Health Research Institutes (NHRI-IACUC-105128A).
: Not applicable.
: HWC and SJL are named on patents relating to the production of recombinant lipidated proteins. The other authors declare that they have no competing interests.